• ARCA for High-Performance mRNA Translation

  2026-09-04

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, enables orientation-controlled Cap 0 mRNA synthesis for efficient translation. This article explains how cap chemistry should be integrated with nanoparticle delivery, neuroinflammation assays, and mRNA therapeutics research.

• Quercetin Inhibits Ferroptosis in Wilson’s Disease

  2026-09-04

  A 2026 Phytomedicine study identifies ferroptosis and phospholipid remodeling as important contributors to Wilson’s disease-associated liver injury. Using animal and cellular models, lipidomics, ACSL4 overexpression, and biophysical assays, the work links Quercetin protection to direct inhibition of the ACSL4/LPCAT3/ALOX15 axis.

• Substance P Workflows for NK-1 Research

  2026-09-03

  Build more reproducible Substance P experiments for pain transmission research, neuroimmune signaling, and receptor-response profiling. This guide combines practical peptide handling with a cautious, data-informed approach to spectral quality control inspired by recent fluorescence-classification research.

• HLTP1 Targets JNK in Hepatic Ischemia-Reperfusion Injury

  2026-09-03

  The 2026 reference study identifies human liver transplantation peptide 1 (HLTP1), an endogenous peptide discovered by peptidomics of human transplant samples, as a candidate treatment for hepatic ischemia-reperfusion injury. Evidence from mouse and AML12 cell models indicates that HLTP1 reduces injury-associated apoptosis by suppressing Jun N-terminal kinase phosphorylation, while JNK activation reverses its protective effects.

• Cy5 Hydrazide for Carbonyl Labeling

  2026-09-02

  Cy5 hydrazide is a carbonyl-reactive fluorescent dye for protein carbonylation labeling and aldehyde and ketone biomolecule labeling. Its far-red signal, high extinction coefficient, and organic-solvent handling requirements support sensitive workflows, including oxidative stress protein detection and fluorescence-based SDS-PAGE.

• Toremifene Citrate: ER Assay Workflows

  2026-09-02

  Toremifene Citrate supports practical estrogen receptor binding, MCF-7 proliferation, and translational exposure studies. This guide turns its receptor-selective pharmacology and formulation constraints into reproducible workflows, assay controls, and troubleshooting decisions for breast cancer research and endocrinology research.

• LY-411575: Gamma-Secretase Inhibitor Workflows

  2026-09-01

  LY-411575 enables controlled suppression of APP and Notch intramembrane cleavage in disease-relevant cell assays. This practical guide connects subnanomolar pathway inhibition with Aβ quantification, NICD monitoring, functional neuronal readouts, and troubleshooting strategies for Alzheimer’s disease research and cancer research.

• Adefovir (GS-0393) Workflows for HBV Research

  2026-09-01

  Adefovir (GS-0393) supports two differentiated workflows: mechanistic hepatitis B virus assays centered on viral DNA polymerase inhibition and OAT1 transport studies that model renal handling. This guide connects evidence-backed benchmarks with practical preparation, dose-ranging, controls, and troubleshooting for reproducible research use.

• Clodronate Liposomes for Causal TAM Studies

  2026-08-31

  Clodronate Liposomes provide a powerful perturbation for testing whether tumor-associated macrophages drive immunotherapy resistance. This article develops an assay-centered framework linking macrophage depletion to CCL7 biology, CD8+ T-cell infiltration, and rigorous experimental controls.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-08-31

  This study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast ferroptosis with defective syncytialization in preeclampsia. Its combination of placental analysis, O-GlcNAc modification proteomics, mechanistic validation, and mouse studies provides a framework for investigating iron-dependent placental injury.

• ABT-263 (Navitoclax) Workflow for Apoptosis

  2026-08-30

  ABT-263, also called Navitoclax, provides a practical way to interrogate Bcl-2 family dependence in cell viability, mitochondrial priming, and caspase-dependent apoptosis research. This workflow connects concentration-controlled apoptosis assays with metabolic sensitization strategies, including FASN inhibition and pediatric acute lymphoblastic leukemia models.

• EZ Cap™ Cre mRNA (m1Ψ) for Precise Editing

  2026-08-29

  Use transient Cre recombinase mRNA to activate loxP-dependent reporters, validate delivery systems, and compare editing workflows without introducing a Cre expression plasmid. Its m1Ψ modification, Cap 1 structure, and poly(A) tail support efficient translation while the reference study shows how delivery design can extend mRNA assays toward extrahepatic tissues.

• Isochlorogenic Acid A Hydrogel for Wound Repair

  2026-08-28

  A 2026 Gels study developed IAA@Fe(III) nanoparticles and embedded them in an amylopectin/carboxymethyl chitosan hydrogel to address the solubility and stability limits of Isochlorogenic acid A. The composite dressing combined antibacterial activity, favorable mechanical and self-healing properties, enhanced cell migration, and improved wound closure in an in vivo model.

• RCN2, PPP2CA, and Cisplatin Resistance in ESCC

  2026-08-28

  A 2026 study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent PPP2CA degradation and PI3K-AKT activation. Its integrated clinical, proteomic, biochemical, and animal-model evidence defines a mechanistic framework for studying treatment-resistant ESCC and prioritizing RCN2 as a therapeutic target.

• I-BET-762: A BET-to-Ferroptosis Assay Framework

  2026-08-27

  I-BET-762 is a selective BET inhibitor that connects epigenetic control with inflammation and ferroptosis research. This article provides a mechanism-to-assay framework for interpreting BRD4-dependent transcription, ROS accumulation, FSP1 regulation, and cell-death phenotypes.

8484 records 1/566 page Next 12345 下5页 Last page